New federal initiatives to enhance the medical treatment of opioid dependence

被引：63

作者：

Fiellin, DA ^{[1
]}

O'Connor, PG ^{[1
]}

机构：

[1] Yale Univ, Sch Med, New Haven, CT 06520 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2002年 / 137卷 / 08期

关键词：

D O I：

10.7326/0003-4819-137-8-200210150-00014

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Opioid dependence is a chronic relapsing medical condition with substantial health and societal complications. Recent federal initiatives are designed to enhance the medical treatment of patients with opioid dependence and will expand the role of internists in the care of these patients. These initiatives include a process for federal exemptions to allow for pharmacologic treatment in office settings, waivers for the use of new medications, and new rules governing the oversight and distribution of opioid agonist medications for maintenance treatment. This perspective describes these initiatives and their implications for internists.

引用

页码：688 / 692

页数：5

共 39 条

[1]

*AM PSYCH ASS, ONL CME PROGR BUPR T

[2] INCLUDING NARCOTIC ADDICTION TREATMENT IN AN OFFICE-BASED PRACTICE [J].